Your Messages Inbox
Your Article Summary
See Latest ArticlesInterleukin-21 as a new therapeutic target for immune-mediated diseases
Trends in Pharmacological Sciences, 07/23/09
Monteleone G et al. – The authors focus on data supporting the pathogenic role of IL–21 in human inflammatory diseases and discuss pre–clinical studies that suggest that neutralization of IL–21 in vivo could be a new biological therapy to combat immune–mediated pathologies, such as inflammatory bowel diseases, diabetes, rheumatoid arthritis and systemic lupus erythematosus.
Related Articles
Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease
World Journal of Gastroenterology, 10/07/09
Relevance Score: 80%
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/16/09
Trends in hypertension treatment in diabetes
Current Hypertension Reports, 12/09/09
New program helps educate survivors of a heart event about the importance of maintaining good physical and emotional health
Daiichi Sankyo, 12/08/09
Article Search
Sponsor